Long Term Care Pharmacy Pays $5.3 Million to Settle Medicare, Medicaid Fraud Allegations
- September 18, 2026
- Written by AHLA Legal Staff
Remedi SeniorCare Holding Corporation has agreed to pay over $5.3 million to the United States to resolve allegations that it billed Medicare and Medicaid for prescription drugs without valid prescriptions, the Department of Justice announced September 17.
According to a press release, from January 1, 2015 through March 31, 2021, Remedi submitted false claims to the Medicare and Medicaid programs for prescription drugs that lacked valid prescriptions but were dispensed anyway to residents of assisted living facilities in various states.
The settlement resolves a whistleblower action filed by Maureen Gearhart and Laura Griffieth, former employees of Remedi. United States ex rel. Gearhart v. Remedi SeniorCare Holding Corp., No. 1:20cv970 (S.D. Ohio).
The settlement resolves allegations only and no determination of liability has been made.